Skip to main content
Caplight Logo









Thesis Care

Thesis Care

Private
New York City, New YorkHealthcare & Life Scienceshttps://thesiscare.com/

Last Round

Series A

Mar 25, 2026

Total Funding Raised

$60M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Thesis Care is a healthcare technology company that provides an AI-powered care team platform designed to deliver scalable clinical capacity for healthcare organizations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, CRM, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

clinical trial management systemCTMSresearch site networkssite network managementclinical trial softwareeClinical solutionspatient recruitmentEHR integrationEMR integrationClinTechsite network CRMclinical trial financial managementSMO softwaresite feasibilityclinical trial analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thesis Care Comparables

Compare Thesis Care with similar companies based on industry and business-model similarity.

Thesis Care comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oracle Solaris
61%
Notable
41%
Credo Health
41%

Thesis Care Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 25, 2026
SeedApr 30, 2024

Key People

Founding team and executive leadership

Aditya Pandyaram

Chief Product Officer & Co-Founder

Founding Team

Niren Gandra

CEO & Co-founder

Founding Team

Thesis Care Investors

Notable investors and investment history

Thesis Care investors
InvestorRounds
Oak HC/FTSeed, Series A
CRVSeries A
Black Opal VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    Grew 16% QoQ, from 37 to 43 employees.

  • Mar 27, 2026

    Now operating as Thesis Care after a $45 million funding round.

Thesis Care Filings

Explore SEC and related filing metadata, where available.

Thesis Care filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Thesis Care's valuation, stock price, and market status.

Is Trovo Health a public or private company?

Trovo Health is a private company.

What is the current stock price of Trovo Health?

Trovo Health is a private company with no public stock price. No recent secondary market data is available.

How much is Trovo Health worth (valuation)?

Valuation information for Trovo Health is not publicly available.

Can I buy Trovo Health stock?

Trovo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Trovo Health's last funding round?

Trovo Health's most recent funding round was Series A on March 25, 2026.

Who are the main investors in Trovo Health?

Key investors in Trovo Health include Oak HC/FT.

Will Trovo Health IPO soon?

No public IPO plans have been announced for Trovo Health.

How can I track Trovo Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trovo Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range33
Year Founded2024
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?